Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 18 May 2023

Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration

in Pharmacoepidemiology

Zhenxiang Gao
Maria Gorenflo
David C. Kaelber
Vincent M. Monnier
Rong Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1181711

3,837 views
7 citations

Original Research

Published on 15 May 2023

Association of maternal personality traits with medication use during pregnancy to appraise unmeasured confounding in long-term pharmacoepidemiological safety studies

in Pharmacoepidemiology

Angela Lupattelli
Nhung T. H. Trinh
Hedvig Nordeng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1160168

2,700 views
1 citation

Original Research

Published on 15 May 2023

Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis

in Pharmacoepidemiology

Clément Mathieu
Julien Bezin
Antoine Pariente

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1129244

1,692 views
1 citation

Original Research

Published on 10 May 2023

Ondansetron: recommended antiemetics for patients with acute pancreatitis? a population-based study

in Pharmacoepidemiology

Ge Wu
Yifei Ma
Wanzhen Wei
Jiahui Zeng
Yimin Han
Yiqun Song
Zheng Wang
Weikun Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155391

10,852 views
2 citations

Original Research

Published on 04 May 2023

Prenatal opioid exposure and risk of asthma in childhood: a population-based study from Denmark, Norway, and Sweden

in Pharmacoepidemiology

Ingvild Odsbu
Marte Handal
Vidar Hjellvik
Sonia Hernandez-Diaz
Helle Kieler
Mette Nørgaard
Svetlana Skurtveit
Buket Öztürk Esen
Milada Mahic

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1056192

2,207 views
1 citation

Original Research

Published on 04 May 2023

Geriatrician-led multidisciplinary team management improving polypharmacy among older inpatients in China

in Pharmacoepidemiology

Yi Song
Lihua Chen
Ying Liu
Xin Xia
Lisha Hou
Jinhui Wu
Li Cao
Li Mo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1167306

3,493 views
4 citations

Original Research

Published on 21 Apr 2023

Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)

in Pharmacoepidemiology

Jesús Cebrino
Silvia Portero de la Cruz

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189644

3,729 views
15 citations

Original Research

Published on 13 Apr 2023

Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis

in Pharmacoepidemiology

Congqin Chen
Danfei Xie
Jie Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1100617

2,308 views
4 citations

Original Research

Published on 13 Apr 2023

Drug-induced tooth discoloration: An analysis of the US food and drug administration adverse event reporting system

in Pharmacoepidemiology

Jun Wang
Dongna Zou
Yuchao Li
Pingping Liu
Chenyu Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161728

28,954 views
13 citations

Original Research

Published on 31 Mar 2023

Adherence to antiretroviral therapy and viral suppression: Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil

in Pharmacoepidemiology

Micheline Marie Milward de Azevedo Meiners
Igor Araújo Cruz
Maria Inês de Toledo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122018

5,802 views
3 citations

Original Research

Published on 24 Mar 2023

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study

in Pharmacoepidemiology

Aniek F. Markus
Victoria Y. Strauss
Edward Burn
Xintong Li
Antonella Delmestri
Christian Reich
Can Yin
Miguel A. Mayer
Juan-Manuel Ramírez-Anguita
Edelmira Marti

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118203

3,203 views
2 citations

Original Research

Published on 24 Mar 2023

Variation in adverse drug events of opioids in the United States

in Pharmacoepidemiology

Edward Y. Liu
Kenneth L. McCall
Brian J. Piper

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163976

5,756 views
5 citations

Original Research

Published on 23 Mar 2023

Random effects modelling versus logistic regression for the inclusion of cluster-level covariates in propensity score estimation: A Monte Carlo simulation and registry cohort analysis

in Pharmacoepidemiology

Mike Du
Albert Prats-Uribe
Sara Khalid
Daniel Prieto-Alhambra
Victoria Y. Strauss

Frontiers in Pharmacology

doi 10.3389/fphar.2023.988605

2,219 views
1 citation

Original Research

Published on 23 Mar 2023

Association of thiamine administration and prognosis in critically ill patients with heart failure

in Pharmacoepidemiology

Rui Yang
Jiasheng Huang
Yumei Zhao
Jia Wang
Dongdong Niu
Enlin Ye
Suru Yue
Xuefei Hou
Lili Cui
Jiayuan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162797

4,494 views
6 citations

Original Research

Published on 22 Mar 2023

Using the national electronic prescription system to determine the primary non-adherence to medication in the Czech Republic

in Pharmacoepidemiology

Jan Bruthans
Jiří Berger
Ján Šoltés
Pavel Michálek

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128457

2,159 views
4 citations

Original Research

Published on 21 Mar 2023

Building an antimicrobial stewardship program: A narrative of six years under the Donabedian perspective

in Pharmacoepidemiology

Amanda Fonseca Medeiros
Caryne Margotto Bertollo
Adriano Max Moreira Reis
Monica Aparecida Costa
Edna Marilea Meireles Leite
Simony da Silva Gonçalves
Mauro Henrique Nogueira Guimarães de Abreu
Renan Pedra de Souza
Maria Auxiliadora Parreiras Martins

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1074389

2,962 views
3 citations